Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Its pivotal trial enrolled 816 participants and met its primary efficacy endpoint, supporting FDA approval in 2010 with documented visceral fat reductions of roughly 15-18% over 26 weeks
To maintain optimal stability, keep the pen away from light, and do not expose it to repeated temperature changes
What is the typical weight loss with AOD-9604
This compensatory hunger amplification contributes to weight regain patterns after stopping appetite-modifying drugs
US$ 25.74
US$ 22.62
US$ 21.43
US$ 26.95
US$ 25.41
US$ 27.95
US$ 28.55
